Recently added
This page was added on 04 June 2018.
Updates made
This page was updated on [date-counter-updated-date]. View history of updates
Registered for use from birth.
Recombinant hepatitis B vaccine
Adult formulation
Each 1.0 mL monodose vial or pre-filled syringe contains:
- 10 µg recombinant hepatitis B surface antigen (HBsAg) protein, adsorbed onto 0.5 mg amorphous aluminium hydroxyphosphate sulfate
Paediatric formulation
Each 0.5 mL monodose vial or pre-filled syringe contains:
- 5 µg recombinant HBsAg protein, adsorbed onto 0.25 mg amorphous aluminium hydroxyphosphate sulfate
Dialysis formulation
Each 1.0 mL monodose vial contains:
- 40 µg recombinant HBsAg protein, adsorbed onto 0.5 mg amorphous aluminium hydroxyphosphate sulfate
All formulations contain latex and may contain yeast proteins.
For Product Information and Consumer Medicine Information about H-B-Vax II visit the Therapeutic Goods Administration website.
Additional vaccine information
For detailed advice on vaccine dosage, administration, contraindications and precautions, and variations from product information, please visit the relevant disease chapter/s.